Annual Long Term Debt
$2.72 B
-$342.39 M-11.17%
December 28, 2024
Summary
- As of February 26, 2025, CRL annual long term debt is $2.72 billion, with the most recent change of -$342.39 million (-11.17%) on December 28, 2024.
- During the last 3 years, CRL annual long term debt has fallen by -$192.54 million (-6.60%).
- CRL annual long term debt is now -12.05% below its all-time high of $3.10 billion, reached on December 31, 2022.
Performance
CRL Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$2.72 B
-$35.49 M-1.29%
December 28, 2024
Summary
- As of February 26, 2025, CRL quarterly long term debt is $2.72 billion, with the most recent change of -$35.49 million (-1.29%) on December 28, 2024.
- Over the past year, CRL quarterly long term debt has dropped by -$113.97 million (-4.02%).
- CRL quarterly long term debt is now -19.00% below its all-time high of $3.36 billion, reached on June 25, 2022.
Performance
CRL Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
CRL Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.2% | -4.0% |
| 3 y3 years | -6.6% | -4.0% |
| 5 y5 years | +38.6% | -4.0% |
CRL Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.1% | at low | -19.0% | at low |
| 5 y | 5-year | -12.1% | +38.6% | -19.0% | +38.6% |
| alltime | all time | -12.1% | >+9999.0% | -19.0% | +1647.6% |
Charles River Laboratories International Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.72 B(-11.2%) | $2.72 B(-1.3%) |
| Sep 2024 | - | $2.76 B(-2.8%) |
| Jun 2024 | - | $2.84 B(-7.8%) |
| Mar 2024 | - | $3.08 B(+0.4%) |
| Dec 2023 | $3.07 B(-1.0%) | $3.07 B(+5.6%) |
| Sep 2023 | - | $2.90 B(-5.7%) |
| Jun 2023 | - | $3.08 B(-2.6%) |
| Mar 2023 | - | $3.16 B(+2.1%) |
| Dec 2022 | $3.10 B(+6.2%) | $3.10 B(-6.3%) |
| Sep 2022 | - | $3.31 B(-1.7%) |
| Jun 2022 | - | $3.36 B(+14.4%) |
| Mar 2022 | - | $2.94 B(+0.8%) |
| Dec 2021 | $2.92 B(+39.9%) | $2.92 B(-7.0%) |
| Sep 2021 | - | $3.14 B(+5.7%) |
| Jun 2021 | - | $2.97 B(+24.9%) |
| Mar 2021 | - | $2.38 B(+13.9%) |
| Dec 2020 | $2.09 B(+6.1%) | $2.09 B(-1.4%) |
| Sep 2020 | - | $2.11 B(-10.2%) |
| Jun 2020 | - | $2.35 B(-4.3%) |
| Mar 2020 | - | $2.46 B(+25.1%) |
| Dec 2019 | $1.97 B(+20.1%) | $1.97 B(-1.7%) |
| Sep 2019 | - | $2.00 B(-6.9%) |
| Jun 2019 | - | $2.15 B(+30.2%) |
| Mar 2019 | - | $1.65 B(+0.8%) |
| Dec 2018 | $1.64 B(+46.9%) | $1.64 B(-1.0%) |
| Sep 2018 | - | $1.65 B(-8.0%) |
| Jun 2018 | - | $1.80 B(+59.0%) |
| Mar 2018 | - | $1.13 B(+1.4%) |
| Dec 2017 | $1.11 B(-7.7%) | $1.11 B(-3.6%) |
| Sep 2017 | - | $1.16 B(+3.6%) |
| Jun 2017 | - | $1.12 B(-4.6%) |
| Mar 2017 | - | $1.17 B(-3.1%) |
| Dec 2016 | $1.21 B(+42.8%) | $1.21 B(-2.1%) |
| Sep 2016 | - | $1.23 B(-7.4%) |
| Jun 2016 | - | $1.33 B(+58.4%) |
| Mar 2016 | - | $840.48 M(-0.7%) |
| Dec 2015 | $846.00 M(+14.2%) | $846.00 M(+1.2%) |
| Sep 2015 | - | $835.80 M(+10.7%) |
| Jun 2015 | - | $754.78 M(+0.0%) |
| Mar 2015 | - | $754.53 M(+1.9%) |
| Dec 2014 | $740.56 M(+15.3%) | $740.56 M(-1.9%) |
| Sep 2014 | - | $754.80 M(-3.4%) |
| Jun 2014 | - | $781.62 M(+27.3%) |
| Mar 2014 | - | $614.13 M(-4.4%) |
| Dec 2013 | $642.35 M(+21.9%) | $642.35 M(+2.9%) |
| Sep 2013 | - | $624.31 M(+0.7%) |
| Jun 2013 | - | $619.77 M(+19.6%) |
| Mar 2013 | - | $518.03 M(-1.7%) |
| Dec 2012 | $527.14 M | $527.14 M(-2.9%) |
| Sep 2012 | - | $543.14 M(-1.5%) |
| Jun 2012 | - | $551.40 M(-18.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $674.74 M(-4.0%) |
| Dec 2011 | $703.19 M(+4.9%) | $703.19 M(-2.4%) |
| Sep 2011 | - | $720.48 M(-1.5%) |
| Jun 2011 | - | $731.42 M(-3.9%) |
| Mar 2011 | - | $761.29 M(+13.6%) |
| Dec 2010 | $670.27 M(+46.5%) | $670.27 M(-4.4%) |
| Sep 2010 | - | $701.08 M(+71.2%) |
| Jun 2010 | - | $409.44 M(-6.5%) |
| Mar 2010 | - | $437.91 M(-4.3%) |
| Dec 2009 | $457.42 M(-15.4%) | $457.42 M(-1.4%) |
| Sep 2009 | - | $463.75 M(-4.7%) |
| Jun 2009 | - | $486.49 M(+2.6%) |
| Mar 2009 | - | $474.15 M(-12.3%) |
| Dec 2008 | $540.65 M(+11.5%) | $540.65 M(+78.0%) |
| Sep 2008 | - | $303.68 M(-2.7%) |
| Jun 2008 | - | $312.26 M(-34.4%) |
| Mar 2008 | - | $476.37 M(-1.8%) |
| Dec 2007 | $485.00 M(-11.3%) | $485.00 M(-1.8%) |
| Sep 2007 | - | $493.70 M(-3.5%) |
| Jun 2007 | - | $511.82 M(-3.0%) |
| Mar 2007 | - | $527.55 M(-3.6%) |
| Dec 2006 | $547.08 M(+110.5%) | $547.08 M(-5.1%) |
| Sep 2006 | - | $576.54 M(+0.8%) |
| Jun 2006 | - | $571.81 M(+111.3%) |
| Mar 2006 | - | $270.65 M(+4.1%) |
| Dec 2005 | $259.90 M(-57.1%) | $259.90 M(-12.7%) |
| Sep 2005 | - | $297.73 M(-8.6%) |
| Jun 2005 | - | $325.68 M(-44.4%) |
| Mar 2005 | - | $585.77 M(-3.3%) |
| Dec 2004 | $605.98 M(+226.4%) | $605.98 M(+225.9%) |
| Sep 2004 | - | $185.96 M(-0.1%) |
| Jun 2004 | - | $186.14 M(-0.0%) |
| Mar 2004 | - | $186.23 M(+0.3%) |
| Dec 2003 | $185.68 M(-3.5%) | $185.68 M(-2.1%) |
| Sep 2003 | - | $189.76 M(-0.1%) |
| Jun 2003 | - | $189.87 M(+0.0%) |
| Mar 2003 | - | $189.85 M(-1.4%) |
| Dec 2002 | $192.48 M(+23.5%) | $192.48 M(+2.1%) |
| Sep 2002 | - | $188.59 M(-0.2%) |
| Jun 2002 | - | $189.05 M(-27.2%) |
| Mar 2002 | - | $259.52 M(+66.5%) |
| Dec 2001 | $155.87 M(-23.0%) | $155.87 M(-19.5%) |
| Sep 2001 | - | $193.65 M(-4.0%) |
| Jun 2001 | - | $201.71 M(-12.6%) |
| Mar 2001 | - | $230.71 M(+13.9%) |
| Dec 2000 | $202.50 M(-47.1%) | $202.50 M(-0.1%) |
| Sep 2000 | - | $202.78 M(-48.4%) |
| Jun 2000 | - | $393.36 M(+0.7%) |
| Mar 2000 | - | $390.46 M |
| Dec 1999 | $382.50 M(>+9900.0%) | - |
| Dec 1998 | $1.19 M | - |
FAQ
- What is Charles River Laboratories International annual long term debt?
- What is the all time high annual long term debt for Charles River Laboratories International?
- What is Charles River Laboratories International annual long term debt year-on-year change?
- What is Charles River Laboratories International quarterly long term debt?
- What is the all time high quarterly long term debt for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly long term debt year-on-year change?
What is Charles River Laboratories International annual long term debt?
The current annual long term debt of CRL is $2.72 B
What is the all time high annual long term debt for Charles River Laboratories International?
Charles River Laboratories International all-time high annual long term debt is $3.10 B
What is Charles River Laboratories International annual long term debt year-on-year change?
Over the past year, CRL annual long term debt has changed by -$342.39 M (-11.17%)
What is Charles River Laboratories International quarterly long term debt?
The current quarterly long term debt of CRL is $2.72 B
What is the all time high quarterly long term debt for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly long term debt is $3.36 B
What is Charles River Laboratories International quarterly long term debt year-on-year change?
Over the past year, CRL quarterly long term debt has changed by -$113.97 M (-4.02%)